glp 1 metabolism GLP-1 and Microbiome Repair for Long-Term GLP-1 Therapy Part 1: Setting
Description
The primary completion date for this trial is slated for June of this year
The duration and the use of a different GLP-1 drug, which may reach different brain targets, may have led to that different outcome
the -MSTN/-ActA group showed only a modest numerical and non-significant body weight decrease from the control group (Fig
Reduced Incretin Effect in Type 2 Diabetes
